Michael Lobban

I bring over 25 years of experience helping medical technology companies move from strong innovation to sustainable international growth. My background spans global medtech leaders and growth-stage companies, where I’ve operated at the intersection of commercial strategy, market access, distributor governance, and capability development across Europe, the Middle East, Asia-Pacific, and Latin America.
What makes me a strong advisor and board member is my ability to translate strategy into executable reality. I’ve repeatedly helped organisations answer the hard questions boards face: Which markets should we enter? With which partners? At what price point? And what capability and risk sits underneath those decisions? I bring a calm, evidence-based perspective shaped by responsibility for multi-market forecasting, pricing strategy, distributor performance, and global budget ownership.

I’m particularly effective as a constructive challenger to executive teams—supporting leadership while ensuring governance, commercial discipline, and long-term value creation aren’t compromised by short-term pressure. My foundation in the Royal Air Force adds a strong bias toward accountability, resilience, and people leadership under pressure

The companies that benefit most from my expertise are medical device and healthcare technology businesses—especially scale-ups, founder-led companies, or corporates launching new platforms internationally—where clinical innovation is strong, but commercialisation, partner strategy, and execution risk need experienced board-level guidance.